Stock 301047 SINO BIOLOGICAL,INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sino Biological,Inc. Share Price

Equities

301047

CNE100004Q23

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
70.95 CNY +1.57% Intraday chart for Sino Biological,Inc. +4.96% -13.90%
24/04 Sino Biological,Inc. Proposes Final Cash Dividend for the Year 2023 CI
23/04 Sino Biological,Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Financials

Sales 2024 * 720M 99.37M 8.28B Sales 2025 * 880M 122M 10.13B Capitalization 9.17B 1.27B 105B
Net income 2024 * 333M 45.96M 3.83B Net income 2025 * 388M 53.55M 4.46B EV / Sales 2024 * 12.7 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 10.4 x
P/E ratio 2024 *
27.6 x
P/E ratio 2025 *
23.6 x
Employees 953
Yield 2024 *
1.99%
Yield 2025 *
-
Free-Float 29.32%
More Fundamentals * Assessed data

Chart Sino Biological,Inc.

Dynamic Chart

Latest news about Sino Biological,Inc.

Sino Biological,Inc. Proposes Final Cash Dividend for the Year 2023 CI
Sino Biological,Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Sino Biological,Inc.'s Equity Buyback Plan announced on February 23, 2024. CI
Sino Biological,Inc. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on February 19, 2024. CI
Bio-Link Pharmaceutical Technology Co., Ltd. announced that it has received funding from Cathay Capital Private Equity SAS, Sino Biological,Inc., Suzhou GSL Venture Capital Management Company, Beijing GSR United Capital Management Consulting Co., Ltd., Tianjin Qianxi Investment Management Partnership Ent. (L.P.), Shanghai Pudong Haiwang Private Fund Management Co., Ltd. and other investors CI
Sino Biological,Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Sino Biological to Acquire Canada’s SignalChem Biotech for $48 Million MT
Sino Biological,Inc. entered into Share Purchase Agreement to acquire SignalChem Biotech Inc. from Signalchem Lifesciences Corporation for CAD 65.85 ?million. CI
Sino Biological,Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Certain A Shares of Sino Biological Inc. are subject to a Lock-Up Agreement Ending on 17-AUG-2023. CI
Sino Biological Unit to Lease Beijing Property to Shenzhou Cell Engineering MT
Sino Biological Buys Land for 918 Million Yuan MT
Sino Biological,Inc Approves the Final Cash Dividend for the Year 2022, Payable on 24 May 2023 CI
Sino Biological,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Sino Biological,Inc. Proposes Final Cash Dividend for the Year 2022 CI
More news

Press releases Sino Biological,Inc.

Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio AQ
Sino Biological Announces Services Partnership with Rapid Novor AQ
Sino Biological: new US centre for bioprocessing AQ
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing AQ
Sino Biological Announces Construction of Its New US-Based Center for Bioprocessing AQ
More press releases

Quotes and Performance

1 day+1.57%
1 week+4.96%
Current month+0.21%
1 month-0.04%
3 months+1.78%
6 months-12.26%
Current year-13.90%
More quotes

Highs and lows

1 week
66.70
Extreme 66.7
71.10
1 month
66.70
Extreme 66.7
73.40
Current year
56.60
Extreme 56.6
83.33
1 year
56.60
Extreme 56.6
103.68
3 years
56.60
Extreme 56.6
368.09
5 years
56.60
Extreme 56.6
368.09
10 years
56.60
Extreme 56.6
368.09
More quotes

Managers and Directors - Sino Biological,Inc.

Managers TitleAgeSince
Jie Zhang CEO
 Chief Executive Officer 51 01/17/01
Jing Wang CHM
 Chairman 39 01/17/01
Tao Feng DFI
 Director of Finance/CFO 43 01/17/01
Members of the board TitleAgeSince
Yong You BRD
 Director/Board Member 51 12/23/12
Shi Zhou Yin BRD
 Director/Board Member 51 26/20/26
Liang Zhi Xie CHM
 Chairman 58 22/16/22
More insiders

ETFs positioned on Sino Biological,Inc.

Name Weight AuM 1st Jan change Investor Rating
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.00% 34 M€ +2.14% -
More ETFs positioned on Sino Biological,Inc.

Quotes

Date Price Change Volume
26/24/26 70.95 +1.57% 539,087
25/24/25 69.85 -0.06% 371,339
24/24/24 69.89 +1.04% 426,107
23/24/23 69.17 +0.67% 353,017
22/24/22 68.71 +1.64% 381,890

End-of-day quote Shenzhen S.E., April 26, 2024

More quotes

Company Profile

Sino Biological Inc is a China-based biotechnology company engaged in the research and development, production, sales and technical services of biological reagents. The Company's main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as the development of recombinant proteins and antibodies, and biological analysis and testing services. The Company operates in the domestic market and overseas markets.
Sector
Biotechnology & Medical Research
Calendar
29/04/2024 - Q1 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Ratings for Sino Biological,Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
70.95 CNY
Average target price
102.5 CNY
Spread / Average Target
+44.47%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SINO BIOLOGICAL,INC. Stock Sino Biological,Inc.
-13.90% 1.27B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 301047 Stock